Innovative,
ready-to-launch OTC medicines available for commercialization

Our proprietary products

In a mission to create unique health solutions for people's well-being, we turned to nature and developed two OTC natural medicines that are our own R&D innovation: Ladiva® and Rosacta®.

Our current portfolio also consists of Violin®, a dietary supplement of the latest generation ingredients for women planning pregnancy, pregnant women and nursing mothers.

ABOUT US

Medis Consumer Health R&D Initiatives

As a dynamically evolving team we are proud of our unique medicinal products, which are the result of our own research and development and aligned with the latest health trends.

As of 2021, both OTC medicines are approved in more than 20 European countries, with plans to expand in the future. We are eager to bringing our innovations to the people through partnerships in all ready-to-launch countries.

  • Carefully selected ingredients
  • Full compliant GACP, EU-GMP, GDP, HACCP, ISO
  • Excellent safety profiles
  • High consumer satisfaction
PARTNERING

PARTNERING

Contact us
as a potential commercialization partner

We are looking for commercialization partners for Europe and beyond.
Our products are registered in 20+ European countries, produced by the highest standards and ready to launch. Get to know us and let us help strenghten your portfolio.

Learn more

Our current partnerships